Characteristics of Montelukast-induced adverse drug reactions in the nervous system

doi:10.19803/j.1672-8629.2022.06.17

Abstract

Abstract: Objective To investigate the clinical characteristics and causes of neurological and mental adverse drug reaction (ADR) induced by montelukast. Methods Such databases as CNKI, Wanfang, VIP and PubMed were searched for related articles published from the inception of databases to February 29, 2020. Case reports and clinical studies on neurological adverse drug reactions (ADR) caused by montelukast were included. Such information as the gender and age of patients, dosage, the time adverse drug reactions in the nervous system occurred and clinical manifestations was classified and summarized. Results A total of 112 patients aged 1 to 86 were collected. ADR mostly occurred in children under 14 years old. The time of intervals ranged from 30 minutes after medication to 2.5 years, and most of them occurred within one week of medication. The main symptoms of ADR were nightmares, sleep disorders, aggressiveness and anxiety. Conclusion Neurologic and mental ADR caused by montelukast are more common in children, and physicians should weigh the potential risks and benefits based on the patient’s condition while remaining alert to the possible risk of suicide.

Key words: montelukast, adverse drug reactions, the nervous and mental system, suicide

CLC Number:

R994.1

CHEN Ruijia, SA Kejia, ZENG Xiaofang. Characteristics of Montelukast-induced adverse drug reactions in the nervous system[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 661-664.

References

[1] CHEN XQ, JIN YY, TANG G, et al.New pharmacology(新编药物学)[M]. Beijing: People's Medical Publishing House, 2018: 531-532.
[2] WU LJ, XIAO GJ.Clinical trial of montelukast combined with budesonide in the treatment of children with cough variation asthma[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2016, 32(22): 2032-2034, 2038.
[3] HE YC.Two cases of adverse reactions were caused by montelukast sodium[J]. Chinese Journal of Clinical Pharmacy(中国临床药学杂志),2008,17(1): 54.
[4] ANANDAN N, IBITOYE F.Montelukast and worsening of hallucinations in paranoid schizophrenia[J]. Psychiatric Bulletin,2008,32(7): 276.
[5] WALLERSTEDT SM,BRUNLÖF G,SUNDSTRÖM A. et al. Montelukast and psychiatric disorders in children[J]. Pharmacoepidemiol Drug Saf, 2009, 8(9): 858-864.
[6] LI XY, ZHOU XY.A case of mental abnormality caused by montelukast sodium[J]. Herald of Medicine(医药导报), 2011, 30(1): 116.
[7] SKILLMAN KL, STUMPF JL.Montelukast-induced anxiety in two pediatric patients[J]. Pharmacotherapy, 2011, 31(5): 90e-95e.
[8] HU SP.Nursing care of 1 case of mental symptoms in children caused by oral Shunerning (montelukast)[J]. Chinese Journal of Misdiagnostics(中国误诊学杂志), 2012, 12(7): 1764.
[9] FEI WS.A case of mental disorder caused by montelukast sodium[J]. Chinese Journal of Coal Industry Medicine(中国煤炭工业医学杂志), 2012, 15(2): 313.
[10] PU ZX, LI YL.Excitement and attention deficit caused by Montelukast in 2 children[J]. Medical Journal of National Defending Forces in Southwest China(西南国防医药), 2012, 22(6): 604.
[11] ZHOU H, ZHANG RF.Pharmaceutical care of a patient with montelukast sodium - induced psychosis[J]. Practical Pharmacy And Clinical Remedies(实用药物与临床), 2012, 15(2): 95-96.
[12] BYRNE F, OLUWOLE B, WHYTE V, et al.Delayed Onset of Neuropsychiatric Effects Associated with Montelukast[J]. Ir J Psychol Med. 2012, 29(2): 125-127.
[13] CALLERO-VIERA A,INFANTE S,FUENTES-APARICIO V,et al.Neuropsychiatric reactions to montelukast[J]. Investig Allergol Clin Immunol, 2012, 22(6): 452-453
[14] CEREZA G, GARCIA DN, LAPORTEJR. Nightmares induced by montelukast in children and adults[J]. Eur Respir J, 2012, 40(6):1574-1575.
[15] KOCYIGIT A, GULCAN OB, YARAR F, et al.Hallucination development with montelukast in a child with asthma: case presentation[J]. Iran J Allergy Asthma Immunol, 2013, 12(4): 397-399.
[16] ALKHUJA S, GAZIZOV N, ALEXANDER ME.Sleeptalking! Sleepwalking! Side effects of montelukast[J]. Case Rep Pulmonol, 2013, 2013: 813786.
[17] WANG XB.A case of abnormal behavior caused by montelukast sodium chewable tablets in children[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2014, 34(10): 858.
[18] LI WJ, HUANG N, ZHU RF.Clinical analysis on psychiatric adverse effects caused by montelukast sodium in children[J]. Adverse Drug Reactions Journal(药物不良反应杂志),2014, (4): 205-208.
[19] IBARRA-BARRUETA O, PALACIOS-ZABALZAI, MORA-ATORRASAGASTI O, et al.Effect of concomitant use of montelukast and efavirenz on neuropsychiatric adverse events[J].Ann Pharmacother, 2014, 48(1): 145-148.
[20] TIAN JX,LI JX,YANG JY, et al.A case of mental disorder caused by montelukast sodium chewable tablets[J]. Journal of Aerospace Medicine(航空航天医学杂志), 2015, 26(7): 916-917.
[21] LI TZ.Analysis of cases of psychiatric symptoms induced by montelukast sodium in asthmatic children[C]. Institute of Hospital Management of National Health and Family Planning Commission.Proceedings of the Chinese Society of Clinical Pharmacy Annual Meeting in 2015 and the 11th China Clinical Pharmacists Forum(2015年中国临床药学学术年会暨第十一届中国临床药师论坛论文集), 2015: 1-3.
[22] WU T, LIN JX.A case report of abnormal night dream in children with pneumonia caused by montelukast sodium chewable tablets[J].Chinese Journal of Clinical Rational Drug Use(临床合理用药杂志), 2017,10(22): 3-5.
[23] LI M, YANG C, YUAN HJ.One case of mental disorders induced by montelukast sodium[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2018, 15(2): 121-123.
[24] ALDEA PA, GARCÍA-SÁIZ M, SANZ ÁE. Psychiatric disorders and montelukast in children: a disproportionality analysis of the VigiBase[J]. Drug Saf, 2016, 39(1): 69-78.
[25] PHILIP G, HUSTAD C, NOONAN G, et al.Reports of suicidality in clinical trials of montelukast[J]. J Allergy Clin Immunol, 2009, 124(4): 691-696.